Literature DB >> 29861159

mTORC1 Promotes Metabolic Reprogramming by the Suppression of GSK3-Dependent Foxk1 Phosphorylation.

Long He1, Ana P Gomes2, Xin Wang3, Sang Oh Yoon2, Gina Lee2, Michal J Nagiec2, Sungyun Cho4, Andre Chavez4, Tasnia Islam4, Yonghao Yu5, John M Asara6, Bo Yeon Kim7, John Blenis8.   

Abstract

The mammalian Target of Rapamycin Complex 1 (mTORC1)-signaling system plays a critical role in the maintenance of cellular homeostasis by sensing and integrating multiple extracellular and intracellular cues. Therefore, uncovering the effectors of mTORC1 signaling is pivotal to understanding its pathophysiological effects. Here we report that the transcription factor forkhead/winged helix family k1 (Foxk1) is a mediator of mTORC1-regulated gene expression. Surprisingly, Foxk1 phosphorylation is increased upon mTORC1 suppression, which elicits a 14-3-3 interaction, a reduction of DNA binding, and nuclear exclusion. Mechanistically, this occurs by mTORC1-dependent suppression of nuclear signaling by the Foxk1 kinase, Gsk3. This pathway then regulates the expression of multiple genes associated with glycolysis and downstream anabolic pathways directly modulated by Foxk1 and/or by Foxk1-regulated expression of Hif-1α. Thus, Foxk1 mediates mTORC1-driven metabolic rewiring, and it is likely to be critical for metabolic diseases where improper mTORC1 signaling plays an important role.
Copyright © 2018 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Foxk1; Foxk2; GSK3; Hif1α; mTOR; metabolism; phosphorylation; transcription

Mesh:

Substances:

Year:  2018        PMID: 29861159      PMCID: PMC6591025          DOI: 10.1016/j.molcel.2018.04.024

Source DB:  PubMed          Journal:  Mol Cell        ISSN: 1097-2765            Impact factor:   17.970


  29 in total

1.  Myogenic stem cell function is impaired in mice lacking the forkhead/winged helix protein MNF.

Authors:  D J Garry; A Meeson; J Elterman; Y Zhao; P Yang; R Bassel-Duby; R S Williams
Journal:  Proc Natl Acad Sci U S A       Date:  2000-05-09       Impact factor: 11.205

Review 2.  14-3-3 proteins: structure, function, and regulation.

Authors:  H Fu; R R Subramanian; S C Masters
Journal:  Annu Rev Pharmacol Toxicol       Date:  2000       Impact factor: 13.820

3.  Binding of 14-3-3 proteins and nuclear export control the intracellular localization of the mitotic inducer Cdc25.

Authors:  A Kumagai; W G Dunphy
Journal:  Genes Dev       Date:  1999-05-01       Impact factor: 11.361

Review 4.  The tuberous sclerosis complex.

Authors:  Peter B Crino; Katherine L Nathanson; Elizabeth Petri Henske
Journal:  N Engl J Med       Date:  2006-09-28       Impact factor: 91.245

Review 5.  Hypoxia signalling in cancer and approaches to enforce tumour regression.

Authors:  Jacques Pouysségur; Frédéric Dayan; Nathalie M Mazure
Journal:  Nature       Date:  2006-05-25       Impact factor: 49.962

6.  Hypoxia-inducible factor determines sensitivity to inhibitors of mTOR in kidney cancer.

Authors:  George V Thomas; Chris Tran; Ingo K Mellinghoff; Derek S Welsbie; Emily Chan; Barbara Fueger; Johannes Czernin; Charles L Sawyers
Journal:  Nat Med       Date:  2005-12-11       Impact factor: 53.440

7.  S6K1 regulates GSK3 under conditions of mTOR-dependent feedback inhibition of Akt.

Authors:  Hui H Zhang; Alex I Lipovsky; Christian C Dibble; Mustafa Sahin; Brendan D Manning
Journal:  Mol Cell       Date:  2006-10-20       Impact factor: 17.970

8.  Proteomic analysis identifies that 14-3-3zeta interacts with beta-catenin and facilitates its activation by Akt.

Authors:  Qiang Tian; Megan C Feetham; W Andy Tao; Xi C He; Linheng Li; Ruedi Aebersold; Leroy Hood
Journal:  Proc Natl Acad Sci U S A       Date:  2004-10-18       Impact factor: 11.205

9.  Loss of Tsc1/Tsc2 activates mTOR and disrupts PI3K-Akt signaling through downregulation of PDGFR.

Authors:  Hongbing Zhang; Gregor Cicchetti; Hiroaki Onda; Henry B Koon; Kirsten Asrican; Natalia Bajraszewski; Francisca Vazquez; Christopher L Carpenter; David J Kwiatkowski
Journal:  J Clin Invest       Date:  2003-10       Impact factor: 14.808

Review 10.  mTOR Complex1-S6K1 signaling: at the crossroads of obesity, diabetes and cancer.

Authors:  Stephen G Dann; Anand Selvaraj; George Thomas
Journal:  Trends Mol Med       Date:  2007-04-23       Impact factor: 11.951

View more
  49 in total

1.  The Global Phosphorylation Landscape of SARS-CoV-2 Infection.

Authors:  Mehdi Bouhaddou; Danish Memon; Bjoern Meyer; Kris M White; Veronica V Rezelj; Miguel Correa Marrero; Benjamin J Polacco; James E Melnyk; Svenja Ulferts; Robyn M Kaake; Jyoti Batra; Alicia L Richards; Erica Stevenson; David E Gordon; Ajda Rojc; Kirsten Obernier; Jacqueline M Fabius; Margaret Soucheray; Lisa Miorin; Elena Moreno; Cassandra Koh; Quang Dinh Tran; Alexandra Hardy; Rémy Robinot; Thomas Vallet; Benjamin E Nilsson-Payant; Claudia Hernandez-Armenta; Alistair Dunham; Sebastian Weigang; Julian Knerr; Maya Modak; Diego Quintero; Yuan Zhou; Aurelien Dugourd; Alberto Valdeolivas; Trupti Patil; Qiongyu Li; Ruth Hüttenhain; Merve Cakir; Monita Muralidharan; Minkyu Kim; Gwendolyn Jang; Beril Tutuncuoglu; Joseph Hiatt; Jeffrey Z Guo; Jiewei Xu; Sophia Bouhaddou; Christopher J P Mathy; Anna Gaulton; Emma J Manners; Eloy Félix; Ying Shi; Marisa Goff; Jean K Lim; Timothy McBride; Michael C O'Neal; Yiming Cai; Jason C J Chang; David J Broadhurst; Saker Klippsten; Emmie De Wit; Andrew R Leach; Tanja Kortemme; Brian Shoichet; Melanie Ott; Julio Saez-Rodriguez; Benjamin R tenOever; R Dyche Mullins; Elizabeth R Fischer; Georg Kochs; Robert Grosse; Adolfo García-Sastre; Marco Vignuzzi; Jeffery R Johnson; Kevan M Shokat; Danielle L Swaney; Pedro Beltrao; Nevan J Krogan
Journal:  Cell       Date:  2020-06-28       Impact factor: 41.582

Review 2.  The Lysosome at the Intersection of Cellular Growth and Destruction.

Authors:  Hijai R Shin; Roberto Zoncu
Journal:  Dev Cell       Date:  2020-06-30       Impact factor: 12.270

Review 3.  GSK-3: a multifaceted player in acute leukemias.

Authors:  Alberto M Martelli; Camilla Evangelisti; Francesca Paganelli; Francesca Chiarini; James A McCubrey
Journal:  Leukemia       Date:  2021-04-02       Impact factor: 11.528

4.  Genome-wide association study of blood lipids in Indians confirms universality of established variants.

Authors:  Khushdeep Bandesh; Gauri Prasad; Anil K Giri; Yasmeen Kauser; Medha Upadhyay; Analabha Basu; Nikhil Tandon; Dwaipayan Bharadwaj
Journal:  J Hum Genet       Date:  2019-03-25       Impact factor: 3.172

5.  Sirt2 Inhibition Enhances Metabolic Fitness and Effector Functions of Tumor-Reactive T Cells.

Authors:  Imene Hamaidi; Lin Zhang; Nayoung Kim; Min-Hsuan Wang; Cristina Iclozan; Bin Fang; Min Liu; John M Koomen; Anders E Berglund; Sean J Yoder; Jiqiang Yao; Robert W Engelman; Ben C Creelan; Jose R Conejo-Garcia; Scott J Antonia; James J Mulé; Sungjune Kim
Journal:  Cell Metab       Date:  2020-08-07       Impact factor: 27.287

6.  Regulation of GSK3 cellular location by FRAT modulates mTORC1-dependent cell growth and sensitivity to rapamycin.

Authors:  Long He; Dennis Liang Fei; Michal J Nagiec; Anders P Mutvei; Andreas Lamprakis; Bo Yeon Kim; John Blenis
Journal:  Proc Natl Acad Sci U S A       Date:  2019-09-06       Impact factor: 11.205

Review 7.  mTOR at the nexus of nutrition, growth, ageing and disease.

Authors:  Grace Y Liu; David M Sabatini
Journal:  Nat Rev Mol Cell Biol       Date:  2020-01-14       Impact factor: 94.444

Review 8.  Molecular logic of mTORC1 signalling as a metabolic rheostat.

Authors:  Alexander J Valvezan; Brendan D Manning
Journal:  Nat Metab       Date:  2019-03-04

Review 9.  Defining the underlying defect in insulin action in type 2 diabetes.

Authors:  Thiago M Batista; Nida Haider; C Ronald Kahn
Journal:  Diabetologia       Date:  2021-03-17       Impact factor: 10.122

Review 10.  Metabolic Regulation of Macrophage Activation.

Authors:  Ourania Kolliniati; Eleftheria Ieronymaki; Eleni Vergadi; Christos Tsatsanis
Journal:  J Innate Immun       Date:  2021-07-09       Impact factor: 7.349

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.